These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18826209)

  • 21. Large-scale evaluation of log P predictors: local corrections may compensate insufficient accuracy and need of experimentally testing every other compound.
    Tetko IV; Poda GI; Ostermann C; Mannhold R
    Chem Biodivers; 2009 Nov; 6(11):1837-44. PubMed ID: 19937825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates.
    Shen M; Xiao Y; Golbraikh A; Gombar VK; Tropsha A
    J Med Chem; 2003 Jul; 46(14):3013-20. PubMed ID: 12825940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
    Tetko IV; Poda GI
    J Med Chem; 2004 Nov; 47(23):5601-4. PubMed ID: 15509156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Druggability indices for protein targets derived from NMR-based screening data.
    Hajduk PJ; Huth JR; Fesik SW
    J Med Chem; 2005 Apr; 48(7):2518-25. PubMed ID: 15801841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo drug design.
    Hartenfeller M; Schneider G
    Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico prediction of ionization constants of drugs.
    Lee PH; Ayyampalayam SN; Carreira LA; Shalaeva M; Bhattachar S; Coselmon R; Poole S; Gifford E; Lombardo F
    Mol Pharm; 2007; 4(4):498-512. PubMed ID: 17629304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive QSPR study of the dissociation constants of diverse pharmaceutical compounds.
    Mercader AG; Goodarzi M; Duchowicz PR; Fernández FM; Castro EA
    Chem Biol Drug Des; 2010 Nov; 76(5):433-40. PubMed ID: 20925694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting myelosuppression of drugs from in silico models.
    Crivori P; Pennella G; Magistrelli M; Grossi P; Giusti AM
    J Chem Inf Model; 2011 Feb; 51(2):434-45. PubMed ID: 21275392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSPR models for the prediction of apparent volume of distribution.
    Ghafourian T; Barzegar-Jalali M; Dastmalchi S; Khavari-Khorasani T; Hakimiha N; Nokhodchi A
    Int J Pharm; 2006 Aug; 319(1-2):82-97. PubMed ID: 16698204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Best of both worlds: combining pharma data and state of the art modeling technology to improve in Silico pKa prediction.
    Fraczkiewicz R; Lobell M; Göller AH; Krenz U; Schoenneis R; Clark RD; Hillisch A
    J Chem Inf Model; 2015 Feb; 55(2):389-97. PubMed ID: 25514239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative structure-retention relationships models for prediction of high performance liquid chromatography retention time of small molecules: endogenous metabolites and banned compounds.
    Goryński K; Bojko B; Nowaczyk A; Buciński A; Pawliszyn J; Kaliszan R
    Anal Chim Acta; 2013 Oct; 797():13-9. PubMed ID: 24050665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of averaging on accuracy of IVIVC model predictions.
    Gaynor C; Dunne A; Davis J
    J Pharm Sci; 2009 Oct; 98(10):3829-38. PubMed ID: 19226628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption.
    Brown MB; Lau CH; Lim ST; Sun Y; Davey N; Moss GP; Yoo SH; De Muynck C
    J Pharm Pharmacol; 2012 Apr; 64(4):566-77. PubMed ID: 22420662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of microarrayed compound screening.
    Hoever M; Zbinden P
    Drug Discov Today; 2004 Apr; 9(8):358-65. PubMed ID: 15081963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of topochemical models for the prediction of permeability through the blood-brain barrier.
    Dureja H; Madan AK
    Acta Pharm; 2007 Dec; 57(4):451-67. PubMed ID: 18165189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An algorithm for evaluating potential tissue drug distribution in toxicology studies from readily available pharmacokinetic parameters.
    Poulin P; Dambach DM; Hartley DH; Ford K; Theil FP; Harstad E; Halladay J; Choo E; Boggs J; Liederer BM; Dean B; Diaz D
    J Pharm Sci; 2013 Oct; 102(10):3816-29. PubMed ID: 23878104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual characterization and diversity quantification of chemical libraries: 1. creation of delimited reference chemical subspaces.
    Le Guilloux V; Colliandre L; Bourg S; Guénegou G; Dubois-Chevalier J; Morin-Allory L
    J Chem Inf Model; 2011 Aug; 51(8):1762-74. PubMed ID: 21761916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational chemistry as an integral component of lead generation.
    Roche O; Guba W
    Mini Rev Med Chem; 2005 Jul; 5(7):677-83. PubMed ID: 16026314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.